NCT07090499 2026-03-19A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT07023731 2026-02-19A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationArvinas Inc.Phase 1/2 Recruiting159 enrolled
NCT07334119 2026-02-19Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsMyeloid TherapeuticsPhase 1 Recruiting60 enrolled
NCT06560645 2026-02-02A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationPrelude TherapeuticsPhase 1 Terminated42 enrolled
NCT06266299 2026-01-28A Study of KK2269 in Adult Participants With Solid TumorsKyowa Kirin Co., Ltd.Phase 1 Recruiting101 enrolled
NCT07277413 2026-01-20A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsIDEAYA BiosciencesPhase 1 Recruiting260 enrolled
NCT07284186 2026-01-16First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsPlexium, Inc.Phase 1 Recruiting155 enrolled